AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vanglimpride 1mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Vanesha Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Vanglimpride 1mg/1000mg Tablet ER

Diabex Duo 1mg/1000mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This formulation assists in regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Vanglimpride 1mg/1000mg Tablet ER

No text provided to rephrase.

Uses of Vanglimpride 1mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Vanglimpride 1mg/1000mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Vanglimpride 1mg/1000mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Vanglimpride 1mg/1000mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Vanglimpride 1mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vanglimpride 1mg/1000mg Extended-Release tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Vanglimpride 1mg/1000mg Tablet ER works:

Each Vanglimpride 1mg/1000mg extended-release tablet unites glimepiride (a sulfonylurea) and metformin (a biguanide), two antidiabetic agents. Glimepiride stimulates pancreatic insulin secretion to reduce blood sugar. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vanglimpride 1mg/1000mg Extended-Release Tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vanglimpride tablets (1mg/1000mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Vanglimpride tablets (1mg/1000mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Vanglimpride 1mg/1000mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Vanglimpride 1mg/1000mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Vanglimpride 1mg/1000mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Vanglimpride 1mg/1000mg Tablet ER :

Should you forget a dose of Vanglimpride 1mg/1000mg Extended-Release Tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vanglimpride 1mg/1000mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vanglimpride 1mg/1000mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vanglimpride 1mg/1000mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels. Also known as MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Vanglimpride 1mg/1000mg Tablet ER, if these symptoms occur.
Vanglimpride 1mg/1000mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Vanglimpride 1mg/1000mg ER tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Vanglimpride 1mg/1000mg ER tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Vanglimpride 1mg/1000mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Vanglimpride 1mg/1000mg ER tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Vanglimpride 1mg/1000mg T...
44
MRP 51
13% off